Dose of contrast material in the MR imaging evaluation of central nervous system tumors.
Yuh
W T
WT
Department of Radiology, University of Iowa College of Medicine, Iowa City 52242.
Halloran
J I
JI
Mayr
N A
NA
Fisher
D J
DJ
Nguyen
H D
HD
Simonson
T M
TM
D000236:Adenoma / Q000175:diagnosis; D001921:Brain / Q000473:pathology*; D001932:Brain Neoplasms / Q000175:diagnosis*; D003287:Contrast Media / Q000008:administration & dosage*; D004338:Drug Combinations; D005682:Gadolinium / Q000008:administration & dosage; D019786:Gadolinium DTPA; D005910:Glioma / Q000175:diagnosis; D006801:Humans; D007089:Image Enhancement; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008536:Meglumine / Q000008:administration & dosage; D009464:Neuroma, Acoustic / Q000175:diagnosis; D009942:Organometallic Compounds / Q000008:administration & dosage; D004369:Pentetic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D010911:Pituitary Neoplasms / Q000175:diagnosis
D003287:Contrast Media; D004338:Drug Combinations; D009942:Organometallic Compounds; D008536:Meglumine; D004369:Pentetic Acid; D005682:Gadolinium; D019786:Gadolinium DTPA